Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia. - Li YR; Shen X; Chen Y; Zhu Y; Huang J; Oliai C; Yang L (Leukemia, 2026)